IPO registrations (S-1, F-1) · Registrants
PULSE BIOSCIENCES, INC.
- SEC CIK
- 1625101 · filings on EDGAR ↗
- Former names
- Electroblate, Inc. (2014–2014)
- Registration
- Form S-1, first filed 2015-12-22, last 2016-05-03; 1 initial registration, 3 amendments
- Outcome
- Final prospectus filed 2017-07-13; declared effective 2016-05-13
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus 3841
- Incorporated in
- DE
- Business address
- 3957 POINT EDEN WAY, Hayward, CA 94545
- EIN
- 46-5696597
- Ticker
- PLSE (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- PULSE BIOSCIENCES, INC. on the corporate pages
Offering terms
- Shares offered
- 1,685,032
- Listing
- Nasdaq under the symbol PLSE
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: PULSE BIOSCIENCES, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: PULSE BIOSCIENCES, INC. Fuzzy (name and state)
- Form 5500 plan sponsor: PULSE BIOSCIENCES, INC EXACT (EIN (EXACT))
- Federal award recipient: PULSE BIOSCIENCES, INC. Fuzzy (name and state)
- Form D issuer: Pulse Biosciences, Inc. EXACT (CIK (EXACT))
- SEC filer: Pulse Biosciences, Inc. EXACT (CIK (EXACT))
- Person page: Kenneth A Clark Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 8
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2015-12-22 | S-1 | S-1 (registration) | Pulse Biosciences, Inc. | 0001193125-15-410608 ↗ |
| 2016-03-07 | S-1/A | S-1/A (amendment) | Pulse Biosciences, Inc. | 0001193125-16-495268 ↗ |
| 2016-03-28 | S-1/A | S-1/A (amendment) | Pulse Biosciences, Inc. | 0001193125-16-519840 ↗ |
| 2016-05-03 | S-1/A | S-1/A (amendment) | Pulse Biosciences, Inc. | 0001193125-16-575202 ↗ |
| 2016-05-13 | EFFECT | EFFECT (declared effective) | Pulse Biosciences, Inc. | 9999999995-16-004652 ↗ |
| 2017-07-11 | EFFECT | EFFECT (declared effective) | Pulse Biosciences, Inc. | 9999999995-17-001787 ↗ |
| 2017-07-11 | EFFECT | EFFECT (declared effective) | Pulse Biosciences, Inc. | 9999999995-17-001788 ↗ |
| 2017-07-13 | 424B4 | 424B4 (final prospectus) | Pulse Biosciences, Inc. | 0001562762-17-000091 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2016-05-03 | S-1/A | registration statement | $4.00 | 5,000,000 | $20,000,000 | Nasdaq PLSE | 0 | primary document; price sentence, shares headline, proceeds computed | document ↗ | |
| 2017-07-13 | 424B4 | final prospectus | 1,685,032 | - | Nasdaq PLSE | 0 | primary document; shares headline | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Dow Brian B | Officer | CFO & SVP Admin. and Finance | 2 | 2016–2017 | |
| Greenberg Robert J. | Director | 3 | 2016–2017 | ||
| LEVANDE ROBERT | DirectorOther | 3 | 2016–2017 | ||
| Levinson Mitchell E. | Director; Director,Officer; Officer | Chief Strategy Officer | 24 | 2016–2024 | |
| NewBEM Corp. | TenPercentOwner | 1 | 2016 | ||
| Old Dominion University Research Foundation | TenPercentOwner | 1 | 2016 | ||
| Thaure Thierry B. | Director | 4 | 2016–2017 | ||
| UECKER DARRIN | Director; Director,Officer; Officer | CEO and President; Chief Technology Officer | 17 | 2016–2026 | |
| Mark & Tammy Strome Family Trust | TenPercentOwner | 1 | 2016 | ||
| Zanganeh Mahkam | Director | 34 | 2017–2026 | ||
| DUGGAN ROBERT W | Director,TenPercentOwner; TenPercentOwner | 57 | 2017–2026 | ||
| Clark Kenneth A | Director | 7 | 2017–2021 | person page Fuzzy | |
| FOGARTY THOMAS J M D | Director | 5 | 2017–2019 | ||
| Soni Manmeet Singh | Director | 13 | 2017–2026 | ||
| Ebbers Ed | Officer | EVP & GM, Dermatology | 4 | 2019–2021 | |
| GARDINER SANDRA A. | Officer | CFO & EVP Admin. and Finance | 4 | 2019–2022 | |
| van den Broek Richard | Director | 8 | 2020–2026 | ||
| DEBUONO LAUREEN | Director | 2 | 2021 | ||
| Spray Shelley D | Director | 4 | 2021–2023 | ||
| Danahy Kevin Patrick | Officer | Chief Commercial Office; Chief Commercial Officer; Chief Executive Officer | 15 | 2022–2026 | |
| Barrett Burke Thomas | Director,Officer; Other | President and CEO | 6 | 2024 | |
| LAVIOLETTE PAUL A | Director; Director,Officer | Chief Executive Officer | 5 | 2024–2026 | |
| Weber Steven | Officer | Principal Accounting Officer | 2 | 2025 | |
| Sainz Maria | Director | 3 | 2026 | ||
| Skinner Jon | Officer | Chief Financial Officer | 2 | 2026 | |
| Teplitsky Liane Rae | Officer | Chief Operating Officer | 4 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2021-07-09 | Pulse Biosciences, Inc. | Other Health Care | $50,000,000 | $50,000,000 | 1 | 1 |
| 2017-09-28 | Pulse Biosciences, Inc. | Biotechnology | $30,040,000 | $30,040,000 | 1 | 1 |
| 2017-02-15 | Pulse Biosciences, Inc. | Biotechnology | $5,000,005 | $5,000,005 | 2 | 1 |
| 2014-11-13 | Electroblate, Inc. | Biotechnology | $8,000,000 | $7,999,997 | 72 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | PULSE BIOSCIENCES, INC. | CA | State business registries | name and state |
| Business registration | PULSE BIOSCIENCES, INC. | CA | State business registries | name and state |
| Plan sponsor | PULSE BIOSCIENCES, INC | CA | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Federal award recipient | PULSE BIOSCIENCES, INC. | CA | Federal spending (USAspending) | name and state |
| Form D issuer | Pulse Biosciences, Inc. | CA | Form D private offerings | CIK (EXACT) |
| Paying company | Pulse Biosciences, Inc. | CA | Open Payments (drug and device company payments) | name and state |
| Patent assignee | Pulse Biosciences, Inc. | CA | Patents (USPTO) | name and state |
| SEC filer | PULSE BIOSCIENCES, INC. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Pulse Biosciences, Inc. | CA | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | PULSE BIOSCIENCES, INC | EIN (EXACT) | ||
| Person page | Kenneth A Clark | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Surgical & Medical Instruments & Apparatus, CA first:
- FUSION MEDICAL TECHNOLOGIES INC CA
- ENDOLOGIX INC /DE/ CA
- CEMAX ICON INC CA
- TRYLON CORP CA
- R2 TECHNOLOGY INC CA
- CERUS CORP CA
- SOMNUS MEDICAL TECHNOLOGIES INC CA
- MICRUS ENDOVASCULAR CORP CA
- AEROGEN INC CA
- IOMED LLC CA
In other datasets, the same topic (Technology) in CA:
- Lobbying client: 8X8, INC. (Federal lobbying (LDA))
Interests: Surgical & Medical Instruments & Apparatus · Technology